(Other)

Mountain View, CA, USA

Aging has been called “the emperor of all maladies.” Turn Bio’s goal is to address multiple aging-related indications using a single powerful reprogramming therapy that turns old cells young again, aiding in the rejuvenation of an aged human body.

In 2013, a paper in Cell (The Hallmarks of Aging, López-Otín et al.) proposed nine key “hallmarks of aging” that are causes of the general phenotype we refer to as “aging.” Our team recognized that it would be necessary to “turn back the clock” on each of these hallmarks and so set out to develop the technology to do just that. The task was achieved by using a proprietary cocktail of transiently administered rejuvenation factors that have now been shown to reverse eight of the nine hallmarks.

Turn Biotechnologies

FORMULATION SCIENTIST (LEVEL I, II, or III)

Khosla Ventures is a financial services company that provides venture assistance and strategic advice to entrepreneurs working on breakthrough technologies.

Khosla Ventures

Join the teams that make the Impossible Happen.

Tell us about your professional DNA to get discovered by any company in our network with opportunities relevant to your career goals.

Leverage our network to build your career.

#### Welcome!

Thank you for joining Khosla Ventures Network!

To help us best support you in your search, please take a few minutes to tell us about what you are looking for in your next role. We’ll use this information to connect you to relevant opportunities in the Khosla Ventures network as they come up.

You can always update this information later.

As our companies grow, they look to us to help them find the best talent.

Signal that you'd be interested in working with a Khosla Ventures company to help us put the right opportunities at great companies on your radar. The choice to pursue a new career move is then up to you.

Thanks for signaling your interest, your profile is now visible to our team and companies in our network.

Welcome to our talent network

Get connected to our portfolio companies.